|Day Low/High||583.76 / 595.48|
|52 Wk Low/High||328.12 / 664.64|
And I was right, and the cynics were wrong. Here's why that matters more than ever now.
The fund is at a key spot technically, and there is real fear that if this spot cracks, what looks like a stretch of rough rapids could become a waterfall.
Just like you have to know how to read a room, you have to know how to read a tape and this tape screams 'I'm not done yet.'
Let's look at this impossible move on the market -- and why health care could be coming off life support.
It looks like it's time to go long Regeneron, as the charts have improved.
The charts are not particularly attractive at this point in time.
Outside of the pro sports world, it seems like amateur hour with regard to protocols.
As power has changed hands in the White House, we can expect these names -- and themes -- to benefit.
The vaccine rollout has been bungled and the nation's in crisis, but you can either dwell on the negativity or look to ingenuity and opportunity. Here's where I see the latter.
A correction in EBS could soon set up an attractive opportunity.
This Friday several banks begin the unofficial kickoff of 'earnings season'.
Most important come Inauguration Day is the seamless transition of leadership over 'Operation Warp Speed'.
Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.
Basically, I think we laid out enough reasons for financial markets to revolt, yet they did not.
What happens when everyone hunkers down, creating their own de facto stay-in-place lockdown?
There is little reason to anticipate a sustained bounce at this point, but there are positive aspects to the price action.
Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.
Let's talk about what's happening right now to get this thing under control and what it will look like not that long from now.
The market is reflecting a triumph of big business over small business, and here's what that means for individual stocks.
I know that Trump's going to blunt our community mask initiative because who needs masks if it isn't a big deal if you are sick?
Even more important than fiscal support moving forward would be the concept of Covid-19 very soon being effectively treatable for the public.
The RMPIA rose 13.8% during the quarter, leaving it up just shy of 29% on a year-to-date basis, thanks to performance by CRM, AAPL , NKE and TMO.
It's remarkable to see such excitement based on totally contradictory theories and themes.